Leadership Transition at Schrödinger: Richie Jain Named CFO
On May 20, Schrödinger, Inc. (NASDAQ:SDGR) announced the departure of Chief Financial Officer Geoffrey Porges, MBBS., who is stepping down to pursue other opportunities.
Schrodinger Inc. (SDGR)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Bill & Melinda Gates Foundation Trust Michael Larson | 6,981,664 | $137,818,047 | 0.33% | |
| 2. | Rubric Capital Management David Rosen | 4,800,000 | $94,752,000 | -4% | 1.7% |
| 3. | ARK Investment Management Catherine D. Wood | 2,294,519 | $45,293,800 | +4% | 0.45% |
| 4. | Cadian Capital Eric Bannasch | 1,105,000 | $21,812,700 | 0.93% | |
| 5. | Citadel Investment Group Ken Griffin | 637,746 | $12,589,106 | +491% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $99.90 | 1,115 | $111,385.94 | 0 | 2021-02-05 | Filing | |
| $17.00 | 588,235 | $9,999,995.00 | 6,981,664 | 2020-02-10 | Filing | |
| $17.00 | 250,000 | $4,250,000.00 | 250,000 | 2020-02-10 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $25.00 | 3,345 | $83,625.00 | 15,625 | 2025-04-14 | Filing | |
| $25.11 | 5,000 | $125,554.50 | 18,970 | 2025-04-14 | Filing | |
| $25.11 | 8,378 | $210,390.85 | 23,970 | 2025-04-14 | Filing | |
| $21.11 | 666 | $14,059.26 | 27,349 | 2025-03-06 | Filing | |
| $21.76 | 5,491 | $119,484.16 | 27,544 | 2025-03-03 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 8,463,746 | $167,074,346 | 0% | |
| 2. | 6,543,845 | $129,175,500 | 0% | |
| 3. | 4,357,532 | $86,017,681 | 0.02% | |
| 4. | 3,462,415 | $68,348,072 | 0.05% | |
| 5. | 2,416,808 | $47,659,454 | 0.61% |
News See All
Schrödinger, Inc. (NASDAQ:SDGR) Q1 2025 Earnings Call Transcript
Operator: Thank you for standing by. Welcome to Schrödinger's conference call to review First Quarter 2025 Financial Results. My name is Calvin, and I'll your operator for today's call.
Bill Gates' 10 Stock Positions with Huge Upside Potential
Bill Gates became the youngest billionaire back in 1987 when he took Microsoft public, and he has been a billionaire since then.
Schrödinger, Inc. (NASDAQ:SDGR) Q4 2024 Earnings Call Transcript
Operator: Thank you for standing by. Welcome to Schrödinger's conference call to review Fourth Quarter and Full Year 2024 Financial Results. My name is Kevin, and I'll your operator for today's call.
Why Xpeng (XPEV) and Schrodinger (SDGR) Are Advancing Today
Xpeng (XPEV) and Schrodinger (SDGR) are climbing 5% and 3.3%, respectively, today after Nasdaq.com reported that institutions had acquired many more shares in the companies than they had sold in recent...
10 AI News And Ratings on Wall Street's Radar
The launch of China’s DeepSeek AI app is prompting investors to question top AI US companies about their high capital spending over the years and negligible returns to show for it.
Top 10 Medical AI Stocks on Wall Street's Radar
Investments in the global healthcare industry have ramped up sharply since the COVID-19 pandemic.
Why These 15 Stocks Are Skyrocketing in 2025
The market has started to favor smaller companies in 2025, and stocks between $1 billion and $5 billion in market value are attracting renewed interest.
Why Drug Developers That Utilize AI, Including SDGR and RXRX, Are Jumping
Pharmaceutical firms that specialize in utilizing AI to speed up the drug discovery process are soaring today.
Schrödinger, Inc. (NASDAQ:SDGR) Q3 2024 Earnings Call Transcript
Operator: Welcome to Schrödinger’s conference call to review our third quarter 2024 financial results. My name is Madison and I will be your Operator for today’s call.